Crkl Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CRK-like proto-oncogene, adaptor protein (CRKL) is a 39 kDa adaptor protein that plays crucial roles in intracellular signaling pathways. It contains SH2 and SH3 domains that enable it to serve as a molecular scaffold linking various signaling proteins.
CRKL (CRK Like Proto-Oncogene) is a protein encoded by a gene located on chromosome 22q11.21. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. CRKL plays important roles in neuronal function and is implicated in neurodegenerative diseases.
| Attribute | Value |
|---|---|
| Protein Name | CRKL |
| Gene Symbol | CRKL |
| UniProt ID | P46108 |
| Molecular Weight | 39 kDa |
| Subcellular Localization | Cytoplasm, Cytoskeleton |
| Protein Family | CRK family (SH2-SH3 adaptor proteins) |
| Tissue Specificity | Brain, hematopoietic cells |
CRKL contains:
CRKL integrates multiple signaling pathways:
CRKL contributes to PD through:
| Strategy | Description | Status |
|---|---|---|
| SH2 domain modulators | Inhibit protein interactions | Research |
| Kinase combinations | Target CRKL upstream kinases | Preclinical |
| Neuroprotective approaches | Maintain CRKL signaling | Experimental |
The study of Crkl Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.